Abstract
Cerebral toxoplasmosis related to AIDS was treated with a combination regimen of pyrimethamine, clindamycin, and spiramycin, and in a second trial with a combination of pyrimethamine and clindamycin. Both regimens proved to be equally effective. The experience with the second trial shows that spiramycin does not provide additional benefit. Myelosuppressive side-effects due to pyrimethamine were prevented in most cases by addition of folinic acid to the regimen at the start of the antitoxoplasmic therapy. These data suggest that the combination of pyrimethamine and clindamycin is an effective alternative to the commonly used regimen consisting of pyrimethamine and sulfonamides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Holliman RE Toxoplasmosis and the acquired immune deficiency syndrome. Journal of Infection 1988, 16: 121–128.
Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. Journal of the American Medical Association 1984, 252: 913–917.
Luft BJ, Remington JS Toxoplasmic encephalitis. Journal of Infectious Diseases 1988, 157: 1–6.
Pohle HD, Eichenblaub D CNS toxoplasmosis in patients with AIDS. AIDS-Forschung 1987, 3: 122–135.
Pohle HD, Eichenlaub D Toxoplasmosis of the CNS in AIDS patients. In: Kubicki ST, Henkes H, Bienzle U, Pohle HD (ed): HIV and the nervous system. Gustav Fischer, Stuttgart, 1988, p. 53–56.
Ruf B, Pohle HD, Iglesias JR Inzidenz und Therapie der Hirntoxoplasmose bei AIDS: Ergebnisse prospektiver Untersuchungen. Mitteilungen der Österreichischen Gesellschaft für Tropenmedizin und Parasitologie 1989, 11: 351–357.
Wong B, Gold JWM, Brown AE, Lange M, Fried R, Grieco M, Mildvan D, Giron J, Tapper ML, Lerner CW, Armstrong D Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers. Annals of Internal Medicine 1984, 100: 36–42.
McCabe RE, Oster S Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 1989, 38: 973–987.
Gordin FM, Simon GL, Wofsy CB, Mills J Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 1984, 100: 495–499.
Mitsuyasu R, Groopman J, Volberding P Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. New England Journal of Medicine 1983, 308: 1535–1536.
Leport C, Bastuji-Garin S, Perronne C, Salmon D, Marche C, Briçaire F, Vildé JL An open study of pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. Journal of Infectious Diseases 1989, 160: 557–558.
Pohle HD, Eichenlaub D Proposal and preliminary results of a treatment regimen with pyrimethamine, clindamycine and spiramycine in toxoplasmosis of the central nervous system. In: Staquet M, Hemmer R, Baert A (ed): Clinical aspects of AIDS and AIDS-related complex. Oxford University Press, New York, 1986, p. 110–113.
Haverkos HW Assessment of therapy for toxoplasma encephalitis: the TE study group. American Journal of Medicine 1987, 82: 907–914.
Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: efficacy of long-term continuous therapy. American Journal of Medicine 1988, 84: 94–100.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruf, B., Pohle, H.D. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system. Eur. J. Clin. Microbiol. Infect. Dis. 10, 183–186 (1991). https://doi.org/10.1007/BF01964457
Issue Date:
DOI: https://doi.org/10.1007/BF01964457